Childhood, adolescent and young adult cancer survivors treated with head or brain radiotherapy or cisplatin have an increased risk of hearing problems. Because of this high risk survivors may benefit from surveillance for hearing loss.
Childhood, adolescent and young adult cancer survivors treated with head or brain radiotherapy or cisplatin have an increased risk of hearing problems. Because of this high risk survivors may benefit from surveillance for hearing loss.
Comments
Thank you. Comment sent for approval.
Something is wrong, try again later